{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "52544-693",
      "generic_name": "Diltiazem Hydrochloride",
      "labeler_name": "Actavis Pharma, Inc.",
      "brand_name": "Matzim LA",
      "active_ingredients": [
        {
          "name": "DILTIAZEM HYDROCHLORIDE",
          "strength": "300 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "52544-693-19",
          "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-693-19)",
          "marketing_start_date": "20110328",
          "sample": false
        },
        {
          "package_ndc": "52544-693-30",
          "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-693-30)",
          "marketing_start_date": "20110328",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, EXTENDED RELEASE",
      "spl_id": "fb6251e2-4e72-4fe6-9e4f-02baf57d97ca",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20110328",
      "product_id": "52544-693_fb6251e2-4e72-4fe6-9e4f-02baf57d97ca",
      "application_number": "ANDA077686",
      "brand_name_base": "Matzim LA",
      "pharm_class": [
        "Calcium Channel Antagonists [MoA]",
        "Calcium Channel Blocker [EPC]",
        "Cytochrome P450 3A4 Inhibitors [MoA]"
      ]
    }
  ]
}